Phase 2 ER Positive Breast Cancer Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Breast CancerER Positive Breast CancerHER2-positive Breast Cancer+1 more

Ruth O'Regan30 enrolled4 locationsNCT04886531

Recruiting

Phase 2

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Breast CancerBreast Cancer FemaleHER2-negative Breast Cancer+2 more

Sarah Sammons, MD58 enrolled3 locationsNCT06176261

Recruiting

Phase 2

Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC

Metastatic Breast CancerER Positive Breast CancerPremenopausal Breast Cancer

National Taiwan University Hospital42 enrolled1 locationNCT05720260